Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...
Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an ...
But perhaps the larger story associated with the unsurprising result is the market reaction, as Novo's shares fell by nearly 9% at the U.S. market open Monday.
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that ...
High blood sugar, hearing loss and low education among strongest dementia risk factors, report finds
High blood sugar, hearing loss and low education are the most prevalent risk factors for dementia in the United States, according to a new report from the Dementia Risk Reduction Project.
Researchers studied the association of risk for MCI and dementia with increasing PET centiloid value in those without CI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback